Cargando…
BSCI-22 DETERMINING THE EFFECT OF NOVEL SMALL MOLECULE DRUGS AGAINST THE MIGRATION OF BRAIN METASTASIS INITIATING CELLS (BMICS)
BACKGROUND: Brain metastases are secondary tumors that predominantly arise from the spread of lung, skin, and breast cancers. The current standard of care for brain metastases is complete surgical resection, with a median survival of four months. Therefore, there is a dire need to discover new thera...
Autores principales: | Mobilio, Daniel, Kieliszek, Agata, Chafe, Shawn, Venugopal, Chitra, Singh, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354213/ http://dx.doi.org/10.1093/noajnl/vdac078.020 |
Ejemplares similares
-
BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021) -
BSCI-18. Identifying novel drivers of lung-to-brain metastasis through in vivo functional genomics
por: Aghaei, Nikoo, et al.
Publicado: (2021) -
39. CHARACTERIZING NOVEL INHIBITORS OF BRAIN METASTASIS-INITIATING CELLS
por: Kieliszek, Agata, et al.
Publicado: (2020) -
BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
por: Singh, Sheila, et al.
Publicado: (2019) -
BSBM-09 IN VIVO CRISPR ACTIVATION SCREEN IDENTIFIES ß-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 1 (BACE1) AS A DRIVER OF NON-SMALL CELL LUNG CANCER BRAIN METASTASIS
por: Chafe, Shawn, et al.
Publicado: (2023)